Professor in the Department of Clinical Neurology at the University of Oxford
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"Objectives: To determine whether plant-derived cannabis medicinal extracts (CME) can alleviate neurogenic symptoms unresponsive to standard treatment, and to quantify adverse effects.
Conclusions: Cannabis medicinal extracts can improve neurogenic symptoms unresponsive to standard treatments. Unwanted effects are predictable and generally well tolerated. Larger scale studies are warranted to confirm these findings."
"A Preliminary Controlled Study to Determine Whether Whole-Plant Cannabis Extracts Can Improve Intractable Neurogenic Symptoms," Clinical Rehabilitation, 2003
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Professor, Department of Clinical Neurology, Radcliffe Infirmary, University of Oxford
Clinical advisor on MS for the National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care
Consultant Neurologist, British Society of Rehabilitation Medicine, Rivermead Rehabilitation Centre, Oxford
Recipient, BMJ Books Non-Commercial Publication Award for co-production of the National Clinical Guidelines for Stroke, 2000
Co-author, "Do Cannabis-Based Medicinal Extracts Have General or Specific Effects on Symptoms in Multiple Sclerosis? A Double-Blind, Randomized, Placebo-Controlled Study on 160 Patients," Multiple Sclerosis, 2004
Co-author, "A Preliminary Controlled Study to Determine Whether Whole-Plant Cannabis Extracts Can Improve Intractable Neurogenic Symptoms," Clinical Rehabilitation, 2003